Frontiers in Bioinformatics is a leading academic journal dedicated to advancing the field of bioinformatics by publishing high-quality research and review articles. Published by FRONTIERS MEDIA SA, this open-access journal aims to foster innovative research, promote collaborative initiatives, and provide a platform for the dissemination of findings related to computational biology, biostatistics, and the intersection of bioinformatics with other biological disciplines. With a focus on promoting accessibility and visibility of research, Frontiers in Bioinformatics operates under a rigorous peer-review process, ensuring that all published content meets the highest academic standards. The journal has shown a commendable rank across various Scopus categories, including Mathematics, Computational Mathematics, and multiple dimensions of Biochemistry and Molecular Biology, indicating its relevance and impact within the research community. Researchers, professionals, and students will find this journal invaluable for staying abreast of the latest developments and breakthroughs in bioinformatics, enhancing their studies and professional projects.

Current Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

Network Modeling and Analysis in Health Informatics and Bioinformatics, published by SPRINGER WIEN, stands as a vital resource in the interdisciplinary domains of health informatics and bioinformatics. With an ISSN of 2192-6662 and E-ISSN of 2192-6670, this journal aims to facilitate the dissemination of innovative research that intersects network modeling, data analysis, and health applications. The journal competes at a Q3 quartile level across multiple categories including Biomedical Engineering and Health Informatics, showcasing its growing influence within the academic community. As of 2023, it holds impressive Scopus rankings, including a 20th position in Urology, illustrating its significance in the field. Although not an open access publication, the journal is dedicated to providing cutting-edge insights from 2012 to 2024 and is poised to attract researchers, professionals, and students striving to push the boundaries of knowledge in health informatics and bioinformatics. This journal is not just a platform for sharing scholarly articles; it is a catalyst for advancing methodologies that enhance patient care and medical research.

Journal of Integrative Bioinformatics, published by WALTER DE GRUYTER GMBH, is a leading open-access journal that has been at the forefront of the field since its inception in 2004. With an E-ISSN of 1613-4516, it serves as a crucial platform for researchers engaged in the interdisciplinary study of bioinformatics, blending insights from biology, computer science, and mathematics. Based in Germany, the journal is recognized for its impact in the realm of general medicine, boasting a Scopus rank of #172 out of 636 and placing in the 73rd percentile of its category. The journal continuously strives to disseminate high-quality research contributions that unify experimental and computational approaches to address complex biomedical questions. Targeted towards academics, professionals, and students alike, the Journal of Integrative Bioinformatics provides essential access to innovative research that enhances our understanding of integrative methodologies in medicine and beyond, especially with converged years spanning from 2008 to 2024.

Computational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

JOURNAL OF COMPUTATIONAL BIOLOGY, published by Mary Ann Liebert, Inc., serves as a premier platform for the dissemination of groundbreaking research at the intersection of biological sciences and computational methods. Established in 1994, this journal provides a valuable resource for researchers, professionals, and students interested in the evolving fields of computational mathematics and biology. With a commendable Q2 ranking in several pertinent categories such as Computational Mathematics and Modeling and Simulation, it emphasizes high-quality studies that propel understanding and innovation in these areas. Although the journal currently operates under traditional access options, it plays a crucial role in fostering scholarly communication and collaboration among a diverse audience, advancing knowledge in genetics, molecular biology, and beyond. The journal's continual evolution, with a commitment to publish until at least 2024, positions it as a critical resource in the fast-paced world of computational biology.

BIOINFORMATICS, published by Oxford University Press, is a leading journal in the realms of biochemistry, computational mathematics, and computer science, with a notable impact factor that underscores its significance in the field. Since its inception in 1985 and continuing through its expected convergence in 2024, the journal has maintained a prestigious reputation, proudly residing in the Q1 category across multiple disciplines, including molecular biology and statistics. With a Scopus ranking placing it within the top percentiles of its categories, BIOINFORMATICS serves as an essential platform for disseminating high-quality research that advances knowledge and innovation at the intersection of biology and computational sciences. This journal not only offers both subscription and open access options, ensuring wider availability of its cutting-edge research, but it has also become a crucial resource for researchers, professionals, and students aiming to stay at the forefront of bioinformatics and related fields. Explore the latest findings and trends that define the future of biological research through this esteemed publication, any inquiries regarding the journal can be directed to its offices located at Great Clarendon St, Oxford OX2 6DP, England.

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.